Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
clinical trials
life sciences
national blog main
biotech
fda
national top stories
new york blog main
boston blog main
boston top stories
eli lilly
new york top stories
alnylam pharmaceuticals
calcitonin gene-related peptide
chronic migraine
episodic migraine
inclisiran
indiana blog main
indiana top stories
migraine
national
new york
novartis
pcsk9 inhibitors
regeneron pharmaceuticals
teva pharmaceutical
abbvie
alder biopharmaceuticals
alirocumab
allergan
biohaven
boulder/denver blog main
boulder/denver top stories
cgpr
cholesterol
david rind
deals
detroit blog main
detroit top stories
drugs
What
fda
5
×
medicines
5
×
drug
new
class
migraine
approval
approved
cholesterol
developed
medco
nod
pain
starts
won
acquire
adults
agreed
allergan
amgen
announced
billion
bringing
brings
candidates
cash
clears
closer
company
compound
deal
decision
eli
filing
gets
head
headache
inched
late
lilly
Language
unset
Current search:
amgen
×
fda
×
medicines
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines